Gudang Garam Tbk PT
OTC:GDNGY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (8.7), the stock would be worth $3.03 (3% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.5 | $2.95 |
0%
|
| 3-Year Average | 8.7 | $3.03 |
+3%
|
| 5-Year Average | 8.6 | $2.99 |
+1%
|
| Industry Average | 10 | $3.48 |
+18%
|
| Country Average | 7.8 | $2.7 |
-8%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$24.3T
|
/ |
Jan 2026
Rp2.8T
|
= |
|
|
$24.3T
|
/ |
Dec 2026
Rp3T
|
= |
|
|
$24.3T
|
/ |
Dec 2027
Rp3.3T
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
|
Gudang Garam Tbk PT
OTC:GDNGY
|
26.8T USD | 8.5 | 17.2 | |
| US |
|
Philip Morris International Inc
NYSE:PM
|
255.6B USD | 19.2 | 22.6 | |
| UK |
|
British American Tobacco PLC
LSE:BATS
|
94.5B GBP | 12.2 | 12.2 | |
| US |
|
Altria Group Inc
NYSE:MO
|
112B USD | 10.8 | 16.2 | |
| JP |
|
Japan Tobacco Inc
TSE:2914
|
10.3T JPY | 13.3 | 20.3 | |
| IN |
|
ITC Ltd
NSE:ITC
|
3.8T INR | 14.2 | 10.8 | |
| UK |
|
Imperial Brands PLC
LSE:IMB
|
22.4B GBP | 8.2 | 10.8 | |
| SE |
S
|
Swedish Match AB
F:SWMC
|
15.2B EUR | 19.9 | 25.4 | |
| KR |
|
KT&G Corp
KRX:033780
|
18.3T KRW | 13.7 | 16.8 | |
| CN |
|
Smoore International Holdings Ltd
HKEX:6969
|
58.9B HKD | 28.6 | 48.9 | |
| ID |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
83.2T IDR | 8.5 | 12.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.4 |
| Median | 7.8 |
| 70th Percentile | 13.9 |
| Max | 1 547 003.1 |
Other Multiples
Gudang Garam Tbk PT
Glance View
Gudang Garam Tbk PT, a prominent name in Indonesia's tobacco industry, traces its roots back to 1958, founded by the visionary Surya Wonowidjojo in the bustling city of Kediri, East Java. The company has grown to become one of the leading manufacturers of kretek, a unique blend of tobacco and clove cigarettes that is deeply embedded in the cultural fabric of Indonesia. The craft of making these aromatic cigarettes involves a meticulous process of selecting and blending high-quality tobacco with distinct Indonesian cloves, a key differentiator that caters to local tastes. This meticulous production system underscores the company’s commitment to quality, ensuring its products remain competitive in an industry dominated by tradition as well as innovation. Financially, Gudang Garam’s success is built largely on its robust distribution network and its ability to scale operations efficiently. The company has harnessed the power of this network not only across Indonesia but also in certain international markets where there is a demand for kretek. By strategically positioning itself as a premium brand through extensive marketing and brand positioning, Gudang Garam maintains a loyal consumer base. This has allowed the company to capitalize on its brand prestige and generate significant revenue from its core products. Meanwhile, despite operating in a heavily regulated industry with growing health concerns, Gudang Garam has demonstrated resilience by continuously innovating its product line to adapt to consumer preferences and regulatory landscapes, ensuring its enduring presence in the market.